Eric Rice, Senior Consultant, Paragon Consulting Partners Up until about six months ago, the idea of having radiologists work remotely wasn’t on the radar for most organizations. In fact, many were strongly opposed to it. That, of course, was before Covid-19 turned healthcare on its head, and strategic plans were thrown out the window. Virtual… Read More »
A worldwide virus-hunting program allowed to expire last year by the Trump administration, just before the coronavirus pandemic broke out, will have a second life — whatever the outcome of the presidential election. Joseph R. Biden Jr. has promised that, if elected, he will restore the program, called Predict, which searched for dangerous new animal… Read More »
Last night the cat tooth fairy visited our house. Not to be confused with the original tooth fairy, the cat tooth fairy comes to replace kitten teeth with a toy or treat. Did you know this? No, neither did I until yesterday. Our kitten Ollie lost two teeth (perfectly normal apparently) and my children were… Read More »
AstraZeneca put the rest of the SGLT2 inhibitor class on notice when its Farxiga scored an FDA heart failure nod in patients with or without diabetes. One of its competitors, Eli Lilly and Boehringer Ingelheim’s Jardiance, is fast on Farxiga’s heels, though, and it’s ready to bring its pivotal trial win in front of physicians. Jardiance, added… Read More »